82 related articles for article (PubMed ID: 421493)
1. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma.
Gano SE; Garcia RL
Cutis; 1979 Feb; 23(2):239-41. PubMed ID: 421493
[TBL] [Abstract][Full Text] [Related]
2. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
[No Abstract] [Full Text] [Related]
3. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
4. A new formula for depigmenting human skin.
Kligman AM; Willis I
Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
[TBL] [Abstract][Full Text] [Related]
5. Rationale for the use of topical corticosteroids in melasma.
Menter A
J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
[TBL] [Abstract][Full Text] [Related]
6. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of retinoic acid in the treatment of melasma.
Pathak MA; Fitzpatrick TB; Kraus EW
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
[TBL] [Abstract][Full Text] [Related]
8. Treatment of melasma (chloasma) by local application of a steroid cream.
Neering H
Dermatologica; 1975; 151(6):349-53. PubMed ID: 1228009
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
11. [A new treatment for vitiligo: topical Kandil therapy combined with oral P.A.B.A].
Pozo Carballido JL
Actas Dermosifiliogr; 1978; 69(11-12):369-74. PubMed ID: 380273
[No Abstract] [Full Text] [Related]
12. [Prescription reference--drug vehicle system: decisive for effect].
Wolf G
Hautarzt; 2007 Dec; 58(12):1008-9. PubMed ID: 18368698
[No Abstract] [Full Text] [Related]
13. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
[TBL] [Abstract][Full Text] [Related]
14. [Double-blind evaluation of the effectiveness and tolerance of tipredane cream and betamethasone valerate cream in patients with psoriasis].
Damasio M; Tacchini GA
G Ital Dermatol Venereol; 1988 Sep; 123(9):IL-LI. PubMed ID: 3243575
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
Cestari T; Adjadj L; Hux M; Shimizu MR; Rives VP
J Drugs Dermatol; 2007 Feb; 6(2):153-60. PubMed ID: 17373174
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of exzema with flupamesone (Flutenal);a double-blind comparison with bethamethasone-17-valerate. (method of simultaneous symmetrical paired comparisons).
Moreno TR; Canas TR; Mestre JM
Curr Ther Res Clin Exp; 1977 Feb; 21(2):183-6. PubMed ID: 403053
[No Abstract] [Full Text] [Related]
17. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
Astaneh R; Farboud E; Nazemi MJ
Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
[No Abstract] [Full Text] [Related]
18. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis.
Weiss SC; Nguyen J; Chon S; Kimball AB
J Drugs Dermatol; 2005; 4(3):339-45. PubMed ID: 15898290
[TBL] [Abstract][Full Text] [Related]
19. A test of the half-side comparative design in the clinical evaluation of topical steroids, using diflucortolone and betamethasone creams.
August PJ; Platt NE; Wiseman RA
Br J Clin Pract; 1985 Oct; 39(10):383-7. PubMed ID: 3907679
[No Abstract] [Full Text] [Related]
20. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
